An ad-hoc group of infectious disease doctors and health researchers on Tuesday held a public meeting to review recent ...

With cases peaking during monsoon seasons and threatening infants and seniors, prevention through vaccination is more important than ever.

With the approach of fall likely bringing the usual uptick in respiratory illness, the provincial government is boosting its ...

Heading into the respiratory illness season, states and clinicians are working to encourage pregnant patients to get COVID-19 ...

Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety and public health impact demonstrated in the ...

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled Retrospective Study Evaluating ...

Respiratory syncytial virus vaccine uptake was low among older veterans, with disparities observed across demographic and social risk factors.